Oxaliplatin is a platinum-based drug, usually classified as alkylating group.

ATC-Code: L01XA03


Strength is denoted by disposable cap color.

RTU (Ready to use) Concentrate:

  • Oxaliplatin Kabi 50 mg/10ml
  • Oxaliplatin Kabi 100 mg/20 ml
  • Oxaliplatin Kabi 200 mg/40 ml

Lyo (Powder):

  • Oxaliplatin Kabi 50 mg
  • Oxaliplatin Kabi 100 mg


Oxaliplatin in combination with 5-fluorouracil and folinic acid is indicated for:

  • Adjuvant treatment of stage III (Duke’s C) colon carcinoma after complete resection of primary tumor
  • Treatment of metastatic colorectal carcinoma

Product Information

​Please note that this product may not be available in all countries due to different registration status.

Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.

If you require any information please contact your local organization.